Guangdong Provincial Key Laboratory of New Drug Screening, School of Pharmaceutical Science, Southern Medical University, Guangzhou 510515, PR China.
Guangdong Provincial Key Laboratory of New Drug Screening, School of Pharmaceutical Science, Southern Medical University, Guangzhou 510515, PR China.
Bioorg Chem. 2019 Jul;88:102914. doi: 10.1016/j.bioorg.2019.04.008. Epub 2019 Apr 10.
A highly efficient method has been developed for the one-pot synthesis of substituted 3-amino-1H-indole and 3-amino-1H-7-azaindole derivatives starting from ethyl 2-cyanophenylcarbamate/ethyl 3-cyanopyridin-2-ylcarbamate, and α-bromoketones in good to excellent yields. All newly synthesized analogues were screened for their antiproliferative activities against four cancer cell lines. The most promising compound 8v demonstrated 13-, 5-, and 1.4-fold improvement compared to fluorouracil in inhibiting HeLa, HepG2, and MCF-7 cell proliferation with IC values of 3.7, 8.0, and 19.9 μM, respectively. Furthermore, 8v induced significant cell cycle arrest at the G/M phase in HeLa cell lines via a concentration-dependent manner. These encouraging findings indicate that the common 3-amino-1H-7-azaindole is a very favorable scaffold for the design of novel anticancer small-molecule drugs.
已开发出一种从乙基 2-氰基苯基氨基甲酸酯/乙基 3-氰基吡啶-2-基氨基甲酸酯和α-溴代酮一锅法高效合成取代的 3-氨基-1H-吲哚和 3-氨基-1H-7-氮杂吲哚衍生物的方法,产率良好至优秀。所有新合成的类似物均进行了抗增殖活性筛选,针对四种癌细胞系。最有前途的化合物 8v 在抑制 HeLa、HepG2 和 MCF-7 细胞增殖方面分别比氟尿嘧啶提高了 13、5 和 1.4 倍,IC 值分别为 3.7、8.0 和 19.9µM。此外,8v 通过浓度依赖性方式在 HeLa 细胞系中诱导明显的 G/M 期细胞周期停滞。这些令人鼓舞的发现表明,常见的 3-氨基-1H-7-氮杂吲哚是设计新型抗癌小分子药物的非常有利的支架。